Immediate Impact

4 by Nobel laureates 14 from Science/Nature 59 standout
Sub-graph 1 of 23

Citing Papers

Polymeric Nanoparticles for Drug Delivery
2024 Standout
Chemically Modified Platforms for Better RNA Therapeutics
2024 Standout
4 intermediate papers

Works of Paul Sims being referenced

Phase II study of a TLR‐9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma
2009
Combination immunotherapy with a CpG oligonucleotide (1018 ISS) and rituximab in patients with non-Hodgkin lymphoma: increased interferon-α/β–inducible gene expression, without significant toxicity
2004

Author Peers

Author Last Decade Papers Cites
Paul Sims 243 313 211 13 753
Sudhasri Mohanty 248 446 304 16 851
Sam Litwin 513 207 243 26 938
Oscar Kashala 349 448 169 27 855
Elana J. Bloom 346 415 150 24 874
Victoria G. Aveson 238 369 343 16 762
Mihail Firan 333 278 314 15 674
René G. Ott 366 454 247 14 918
Patrick Squiban 443 316 62 32 955
Rajesh Vij 103 358 140 13 712
Kim C. M. Santegoets 441 243 71 20 843

All Works

Loading papers...

Rankless by CCL
2026